Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 188,221	$ 99,806
Prepaid expenses and other current assets	754	1,037
Total current assets	188,975	100,843
Property and equipment, net	44
Other assets	52
Total assets	189,071	100,843
Current liabilities:
Accounts payable and accrued expenses	18,244	20,302
Total current liabilities	18,244	20,302
Private placement warrants		990
Total liabilities	18,244	21,292
Commitments and contingencies (Note 9)
Redeemable noncontrolling interest	16,240	18,680
Shareholders' Equity:
Preferred shares, $0.0001 par value, 1,000,000 authorized as of September 30, 2024, and December 31, 2023; -0- issued and outstanding as of September 30, 2024, and December 31, 2023
Class A Ordinary Shares, $0.0001 par value, 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 65,293,530 and 43,593,678 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	7	4
Additional paid-in capital	295,311	162,820
Accumulated deficit	(142,272)	(103,494)
Total Zura Bio Limited shareholders' equity	153,046	59,330
Noncontrolling interest	1,541	1,541
Total shareholders' equity	154,587	60,871
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 189,071	$ 100,843

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.